Sun Pharmaceutical Industries Limited (BOM:524715)
1,989.35
-11.40 (-0.57%)
At close: Jul 31, 2026
BOM:524715 Stock Forecast
Stock Price Forecast
According to 34 analysts polled by S&P Global, BOM:524715 stock has a consensus rating of "Buy" and an average price target of ₹2,085. The average 1-year stock price forecast is 4.81% higher than the current stock price, while the lowest is ₹1,650 (-17.06%) and the highest is ₹2,366 (+18.93%).
Price Target: ₹2,085 (+4.81%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:524715 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 24 | 23 | 22 | 20 | 20 | 20 |
| Buy | 9 | 9 | 7 | 10 | 10 | 10 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 1 | 1 | 1 | 1 |
| Total | 37 | 36 | 32 | 34 | 34 | 34 |
Financial Forecast
Revenue This Year
654.30B
from 584.62B
Increased by 11.92%
Revenue Next Year
729.70B
from 654.30B
Increased by 11.52%
EPS This Year
54.85
from 52.01
Increased by 5.45%
EPS Next Year
64.28
from 54.85
Increased by 17.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.